权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Multiplexed Point Of Care Nucleic Acid Assay for STI

STI 多重护理点核酸检测

基本信息

批准号：
9074908
负责人：
KUMAR SUBRAMANIAN
金额：
$ 19.79万
依托单位：
PHOENIX BIOSYSTEM, INC.
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
起止时间：
2016-08-15 至 2018-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9074908
关键词：
Accident and Emergency department Address Affordable Care Act Alabama Antimicrobial susceptibility Archives Area Bacterial Vaginosis Biological Assay Biometry Budgets Caliber Caring Chlamydia Clinic Clinical Communicable Diseases Communities Cost of Illness Cost-Benefit Analysis Country County Custom Cyclopentane DNA Detection Diagnosis Diagnostic Diagnostic tests Disease Epidemiology Evaluation Exhibits Future Gonorrhea HIV HIV Infections Health Healthcare Healthcare Systems Hepatitis Human Papillomavirus Individual Infant Infection Infertility Laboratories Laboratory Research Laboratory Scientists Licensing Life Malignant Neoplasms Marketing Medicine Modeling National Institute of Diabetes and Digestive and Kidney Diseases Nucleic Acid Amplification Tests Nucleic Acid Probes Nucleic Acids Ophthalmology Optics Organic Chemistry Organism Pathogenesis Patients Pattern Pelvic Inflammatory Disease Peptide Nucleic Acids Physician Executives Physicians&apos Offices Population Primary Health Care Provider Research Research Personnel Ribosomal RNA Sampling Sepsis Sexually Transmitted Diseases Simplexvirus Source Specificity Statistical Data Interpretation Swab Syphilis System Technology Test Result Testing TimeLine Trichomonas Trichomonas Infections Trichomonas vaginalis United States Universities Urinary tract infection Vagina Validation Viral Load result Visit Woman assay development base care systems communicable disease diagnosis cost effective cross reactivity design experience follow-up human subject inner city innovation nanoscale nucleic acid detection pathogen perinatal outcomes professor public health relevance reproductive

项目摘要

DESCRIPTION (provided by applicant): With nearly 20 million new infections annually, sexually transmitted diseases (STDs) are very common in the United States. And with recent changes to the national health care landscape, including the passage of the Affordable Care Act and state budget cuts resulting in the closure of STD and HIV clinics, primary care providers can expect to encounter more patients with STDs. For women and infants, STDs can have serious and long-term consequences, including infertility, facilitation of HIV infection, reproductive trac cancer, pelvic inflammatory disease, and poor perinatal outcomes. STDs cost the US health care system nearly $16 billion every year. The ability to obtain easily available and sensitive Nucleic Acid Based Point Of Care (POC) tests in primary care clinics and inner city clinics may have a far reaching impact on the rates of STDs in this country. From modeling and cost-benefit analyses the bottom line for rapid, accurate, sensitive diagnostic tests is clear - when we have them, we should use them. We propose to develop rapid, accurate, sensitive and cost effective Nucleic Acid based POC system to fulfill the unmet market needs. The system can be readily expanded to include other tests in the future including HIV-Viral load, Hepatitis, Syphilis, MGen, HPV and BV.